11/17/2025
https://www.ijidonline.com/article/S1201-9712(25)00416-3/fulltext
BREAKING: Massive South Korean Study of 51 Million People Links COVID Vaccines to Skyrocketing Respiratory Risks—Up to 559% Increase in Children
A bombshell analysis is sending shockwaves through public health circles. A groundbreaking study of South Korea's entire population (51.6 million strong) reveals alarming dose-dependent spikes in non-COVID respiratory infections among the vaccinated.
Published in the Cureus journal, the research led by epidemiologist Nicolas Hulscher of the McCullough Foundation shows each additional mRNA shot erodes immune defenses.
Individuals, especially children, become more vulnerable to everyday bugs like the common cold and upper respiratory infections (URIs).
The data stands as the most comprehensive available.
From June 2023 to September 2024, researchers tracked vaccination records and health outcomes for over 39 million people.
They adjusted for age, s*x, income, comorbidities, and prior COVID infections.
The results show clear escalation with every dose.
• Children (ages 0-19): The hardest hit. After four or more doses, common cold risk surges 559%, URIs rise 251%, and pneumonia increases 91% in those without prior COVID.
• Seniors (65+): Still vulnerable. Common cold odds climb 58% after four doses.
• Overall trends: Pooled hazard ratios show a 23% jump in colds after three doses. Risks balloon to 65% after four or more. Tuberculosis risks rise 24-35% in COVID-positive subsets.
Hulscher states plainly: "This massive dataset shows a consistent dose-dependent pattern: the more COVID-19 'vaccines' a person received, the higher their risk of developing the common cold and upper-respiratory infections."
He flags a potential "VAIDS" signal (vaccine-acquired immune deficiency syndrome) driven by immune exhaustion and IgG4 antibody shifts that weaken broad protection.
Key caveats apply.
The "unvaccinated" baseline includes single-dose individuals. This likely understates the gap versus zero doses.
Apparent reductions in flu-like illnesses stem from coding biases and "healthy user" effects, not genuine benefits.
Korea's 46-fold pertussis surge in 2023 underscores the reality.
This Korean data signals a global concern.
Hulscher concludes: "COVID-19 'vaccines' have eroded immune function across an entire country (and likely the entire globe)."
Ongoing research into T-cell fatigue and antibody profiles raises urgent implications.
Since the COVID-19 pandemic waves (2020–2022), numerous countries have witnessed substantial alterations of public health infrastructure, individual hygiene practices, healthcare accessibility, and patterns of diseases [1–4]. As our society has gradually transitioned into the end of the pandemic...
